|
Aug 11
|
CareDx Comments on Issuance of Proposed LCD for Molecular Testing for Solid Allograft Rejection
|
|
Aug 9
|
Compared to Estimates, CareDx (CDNA) Q2 Earnings: A Look at Key Metrics
|
|
Aug 8
|
CareDx (CDNA) Reports Q2 Loss, Tops Revenue Estimates
|
|
Aug 8
|
CareDx Reports Second Quarter 2023 Results
|
|
Aug 7
|
CareDx Announces District Court Judge Bars Natera from Falsely Advertising and Overstating the Scientific Performance of its Prospera Transplant Test
|